Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10
Background. Targeting interleukin-6 (IL-6) was shown to counteract donor-specific antibody production and antibody-mediated rejection (AMR) activity. It is not known whether, or to what extent, IL-6 antagonism modulates biomarkers indicative of tissue damage (donor-derived cell-free DNA [dd-cfDNA])...
Main Authors: | Katharina A. Mayer, MD, Konstantin Doberer, MD, Philip F. Halloran, MD, PhD, Klemens Budde, MD, Susanne Haindl, BSc, Jakob Mühlbacher, MD, PhD, Farsad Eskandary, MD, PhD, Thierry Viard, PhD, Silvia Casas, PhD, Bernd Jilma, MD, Georg A. Böhmig, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-12-01
|
Series: | Transplantation Direct |
Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001406 |
Similar Items
-
Comparing Three Different Anti–Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study
by: Yuki Katayama, MD, PhD, et al.
Published: (2024-03-01) -
Histological analysis of psoriasiform eruption associated with myelin oligodendrocyte glycoprotein antibody-associated disease
by: Saori Itoi-Ochi, MD, PhD, et al.
Published: (2024-04-01) -
Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
by: Anu K. Kaskinen, MD, PhD, et al.
Published: (2023-10-01) -
Potential Efficacy of Shiunko for Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody-Induced Skin Fissure: A Single Institutional Case Series
by: Mashiro Okunaka PhD, et al.
Published: (2024-01-01) -
Radiolabeled Anti-Adenosine Triphosphate Synthase Monoclonal Antibody as a Theragnostic Agent Targeting Angiogenesis
by: Bok-Nam Park PhD, et al.
Published: (2017-12-01)